Using Gas Chromatography – Tandem Mass Spectrometry to Improve the Reliability and Accuracy of Organic Acid Analyses in Urine

Significance of the Topic

Organic acids in urine serve as biomarkers for inborn metabolic disorders, aiding early diagnosis and treatment monitoring in pediatric and clinical settings. High matrix complexity of urine challenges accurate quantitation by traditional GC–MS. Incorporating tandem mass spectrometry addresses interference issues and enhances reliability.

Objectives and Study Overview

This application note describes the development and evaluation of a GC–MS/MS method using a Bruker 320-MS coupled with a liquid autosampler to quantify fifteen organic acids in newborn urine. The primary aim is to demonstrate improved specificity, sensitivity, and calibration linearity compared to single-quadrupole GC–MS screening.

Methodology and Instrumentation

Sample Preparation:

• Determine urine creatinine levels.
• Add internal standard mix and acidify with HCl, then vortex.
• Perform solid-phase extraction on Chem Elut columns and elute with ethyl acetate.
• Evaporate under N₂ and derivatize with Regisil RC-2 (BSTFA) at 96 °C for 20 minutes.
• Reconstitute in ethyl acetate and transfer to autosampler vials.

Instrumental Conditions:

• Gas Chromatograph: 5% phenyl/95% dimethylpolysiloxane column (30 m × 0.25 mm ID, 0.25 μm df), helium carrier at 1 mL/min, injector at 250 °C (50:1 split), 1 µL injection.
• Oven Program: 90 °C (1.5 min), ramp to 130 °C at 10 °C/min (1 min), to 250 °C at 10 °C/min (1 min), to 280 °C at 15 °C/min (10 min).
• Tandem MS: Electron ionization (70 eV), 2.0 mTorr argon collision gas, source 200 °C, transfer line 280 °C, Q1/Q3 peak widths 0.7/3.0 Da, dwell time 100 ms, EDR detector.

Main Results and Discussion

Multiple-reaction monitoring (MRM) chromatograms of representative acids showed clear separation and reduced urine matrix interference. Calibration curves for fifteen analytes plus internal standard yielded R² values from 0.975 to 0.999. Estimated detection limits ranged from 0.07 to 5.5 nmol/mL (6 to 800 ppb). The MS/MS approach provided enhanced signal-to-noise ratios and superior linearity versus single-quadrupole methods.

Benefits and Practical Applications

• Improved specificity and reduced matrix effects enable more accurate compound identification.
• Enhanced calibration linearity supports reliable quantitation across clinical concentration ranges.
• Streamlined workflow with SPE and derivatization facilitates high-throughput newborn screening and metabolic disorder diagnostics.

Future Trends and Potential Applications

Integration of high-resolution MS/MS is expected to further lower detection limits and expand analyte panels. Automation of sample preparation and data processing may accelerate clinical adoption. Emerging metabolomics workflows could leverage this method for comprehensive biomarker profiling and personalized diagnostics.

Conclusion

The described GC–MS/MS method using a Bruker 320-MS significantly improves the reliability and accuracy of urinary organic acid analysis. By mitigating matrix interferences and achieving robust calibration, this approach advances newborn screening and supports more effective diagnosis of metabolic disorders.

Instrumentation

• Bruker 320-MS tandem mass spectrometer
• CTC Combi-PAL liquid autosampler